1-7 of 7
Veronique Mansat-De Mas
Close
Sort by
Journal Articles

Markers of Oxidative Stress Do Not Correlate with Labile Plasma Iron Blood in Patients with Myelodysplastic Syndromes

Christian Rose, MD, Fathi Driss, Veronique Mansat De Mas, Odile Beyne-Rauzy, MD PhD, Emmanuel Gyan, MD PhD, Yongmin MA, Robert Hider, Pierre Fenaux, MD PhD, Carole Beaumont, PhD
Journal: Blood
Blood (2015) 126 (23): 2149.
https://doi.org/10.1182/blood.V126.23.2149.2149
Published: 2015
Journal Articles

Immunophenotypic-Defined Stage of Leukemia Differentiation Arrest Identifies Oncogenic and Metabolic Signatures in AML

Francois Vergez, DVM, PhD, Sarah Bertoli, MD PhD, Marina Bousquet, PhD, Marie-Laure Nicolau-Travers, Michael Peres, PharmD, Estelle Saland, Françoise Huguet, MD, Isabelle Luquet, MD, Veronique Mansat-de Mas, PharmD, PhD, Cecile Demur, MD, Eric Delabesse, MD PhD, Gwenn Danet-Desnoyers, PhD, Jean-Emmanuel Sarry, PhD, Christian Récher, MDPhD
Journal: Blood
Blood (2015) 126 (23): 90.
https://doi.org/10.1182/blood.V126.23.90.90
Published: 2015
Journal Articles

Time from diagnosis to intensive chemotherapy initiation does not adversely impact the outcome of patients with acute myeloid leukemia

Clinical Trials & Observations
Sarah Bertoli, Emilie Bérard, Françoise Huguet, Anne Huynh, Suzanne Tavitian, François Vergez, Sophie Dobbelstein, Nicole Dastugue, Véronique Mansat-De Mas, Eric Delabesse, Eliane Duchayne, Cécile Demur, Audrey Sarry, Valérie Lauwers-Cances, Guy Laurent, Michel Attal, Christian Récher
Journal: Blood
Blood (2013) 121 (14): 2618–2626.
https://doi.org/10.1182/blood-2012-09-454553
Published: 2013
Includes: Supplemental data
Journal Articles

High frequency of GATA2 mutations in patients with mild chronic neutropenia evolving to MonoMac syndrome, myelodysplasia, and acute myeloid leukemia

Marlène Pasquet, Christine Bellanné-Chantelot, Suzanne Tavitian, Naïs Prade, Blandine Beaupain, Olivier LaRochelle, Arnaud Petit, Pierre Rohrlich, Christophe Ferrand, Eric Van Den Neste, Hélène A. Poirel, Thierry Lamy, Marie Ouachée-Chardin, Véronique Mansat-De Mas, Jill Corre, Christian Récher, Geneviève Plat, Françoise Bachelerie, Jean Donadieu, Eric Delabesse
Journal: Blood
Blood (2013) 121 (5): 822–829.
https://doi.org/10.1182/blood-2012-08-447367
Published: 2013
Includes: Supplemental data
Journal Articles

The cell cycle regulator CDC25A is a target for JAK2 V617F oncogene

Emilie-Fleur Gautier, Muriel Picard, Camille Laurent, Caroline Marty, Jean-Luc Villeval, Cécile Demur, François Delhommeau, Elizabeth Hexner, Stéphane Giraudier, Nicolas Bonnevialle, Bernard Ducommun, Christian Récher, Guy Laurent, Stéphane Manenti, Véronique Mansat-De Mas
Journal: Blood
Blood (2012) 119 (5): 1190–1199.
https://doi.org/10.1182/blood-2011-01-327742
Published: 2012
Includes: Supplemental data
Journal Articles

IDH1/2, TET2 and DNMT3A Mutations Are Not Mutually Exclusive in Secondary Acute Myeloid Leukemias,

Olivier Kosmider, Olivier LaRochelle, Marie-Magdelaine Coude, Veronique Mansat-De Mas, Eric Delabesse, Pascale Cornillet-Lefebvre, Odile Blanchet, Christian Recher, Alain Delmer, MD, Sophie Raynaud, Catherine Lacombe, Olivier Bernard, Norbert Ifrah, Francois Dreyfus, Michaela Fontenay
Journal: Blood
Blood (2011) 118 (21): 3556.
https://doi.org/10.1182/blood.V118.21.3556.3556
Published: 2011
Journal Articles

TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs)

Olivier Kosmider, Véronique Gelsi-Boyer, Meyling Cheok, Sophie Grabar, Véronique Della-Valle, Françoise Picard, Franck Viguié, Bruno Quesnel, Odile Beyne-Rauzy, Eric Solary, Norbert Vey, Mathilde Hunault-Berger, Pierre Fenaux, Véronique Mansat-De Mas, Eric Delabesse, Philippe Guardiola, Catherine Lacombe, William Vainchenker, Claude Preudhomme, François Dreyfus, Olivier A. Bernard, Daniel Birnbaum, Michaëla Fontenay, on behalf of the Groupe Francophone des Myélodysplasies
Journal: Blood
Blood (2009) 114 (15): 3285–3291.
https://doi.org/10.1182/blood-2009-04-215814
Published: 2009
Includes: Supplemental data